Avaí Bio and Austrianova have completed a Master Cell Bank (MCB) of genetically modified cells that overexpress the α-Klotho protein, a key anti-aging protein. This milestone is crucial for producing consistent, safe cell-based therapies targeting aging and related diseases like kidney and neurodegenerative disorders. The MCB will undergo rigorous viral and contamination testing before progressing to create a Working Cell Bank for clinical product manufacturing. This step advances their joint venture Klothonova's goal to develop sustainable α-Klotho therapies for age-related conditions.
The FDA has accepted ImmunityBio's supplemental Biologics License Application (sBLA) for ANKTIVA to treat BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). This acceptance marks a key advancement for the company, with a PDUFA action date s...
The IT and digital infrastructure market is rapidly expanding due to increased enterprise spending on cloud computing, AI integration, cybersecurity, and managed services. The U.S. IT services market alone reached $405.7 billion in 2023 and is projec...
OpenAI and Google have significantly increased their AI investments in Singapore, establishing the city-state as a key AI hub in Asia-Pacific. OpenAI opened its first applied AI lab outside the U.S. in Singapore, backed by a S$300 million commitment,...
Holzer & Holzer, LLC announced approaching deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Vital Farms, Super Micro Computer, and Aldeyra Therapeutics. These lawsuits allege misleading statements or ...
Lifestyle expert Meaghan B. Murphy shares easy Memorial Day hosting tips featuring Wendy's upgraded Spicy Chicken Sandwich with a juicier marinade and bold spices, and a healthy Mediterranean Tuna Salad using Genova Premium Tuna. These food ideas com...
